While Sanofi’s immunology megablockbuster Dupixent predictably dominated the company’s sales charts in 2024, a new golden ...

A panel discussion during the JPMorgan conference earlier this month examined where oncology drug development is headed, driven in part by advances in diagnostic testing.

Over-exposure to an allergen also raises the risk of allergies, says David Cor ry, MD, professor of medicine in the section ...

Induces potent and long-lasting immune responses to defined antigens or whole pathogens (particles), mainly through the ...

A board-certified immunologist clears the air—turns out, there's only one time when allergies can lead to a fever.

A study led by Hiroshi Ohno at the RIKEN Center for Integrative Medical Sciences (IMS) recently showed that certain gut ...

Under terms of the deal, AbbVie will provide Neomorph with an upfront payment and the potential to earn up to $1.64 billion ...

AbbVie and Neomorph are set to enter a partnership and option-to-license agreement to develop molecular glue degraders.

In the midst of pandemic upheaval, researchers have gained fundamental insights about how the body fends off infections.

An exciting collaboration between the Ragon Institute and the Jameel Clinic at MIT has achieved a significant milestone in leveraging artificial intelligence (AI) to aid the development of T cell ...

Researchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg~Kimmel Institute for Cancer Immunotherapy have developed a computer model to help scientists identify tumor-fighting immune cells in ...

With every bite of food we take, our intestinal immune system must make a big decision. Tasked with defending us from foreign ...